---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-123681"
form_type: "8-K"
ticker: "FLGT"
cik: "0001674930"
company_name: "Fulgent Genetics, Inc."
filed_at: "2024-11-08T23:59:59+00:00"
generated_at: "2026-05-30T02:53:14.171568+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Fulgent Q3 core rev $71.7M (+9% YoY), GAAP loss $0.48, non-GAAP EPS $0.31; guides FY core rev $280M

## Summary
- Total revenue $71.7M, core revenue (ex-COVID) $71.7M, up 9% YoY.
- GAAP net loss $14.6M ($0.48 per share); non-GAAP net income $9.4M ($0.31 per share).
- Adjusted EBITDA income $0.4M; cash and marketable securities $815.4M.
- Reiterated FY2024 core revenue guidance of $280M; improved EPS guidance for 2024.

## SEC filing metadata
- accession: 0000950170-24-123681
- form_type: 8-K
- ticker: FLGT
- cik: 0001674930
- company_name: Fulgent Genetics, Inc.
- filed_at: 2024-11-08T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1674930/000095017024123681/0000950170-24-123681-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1674930/000095017024123681/flgt-20241108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-123681
- JSON: https://secwatch.observer/filing/0000950170-24-123681.json
- Plain text: https://secwatch.observer/filing/0000950170-24-123681.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.